Draft Agenda

Current Trends in Immuno-Oncology of Melanoma

Belgrade, May 09, 2018
Hotel Radisson Blu, Belgrade, Serbia

 

Till 13:00
 Arrivals Speakers
13:00 – 14:00 Lunch
14:00 – 14:15 Welcome and Introduction

  • Review program objectives
  • Outline agenda
 Lidija  Kandolf Sekulović (SER)
Siniša Radulović (SER)
14:15 – 14:30 Introduction to Immuno-Oncology of melanoma

  • Melanoma as a model tumor for immuno-oncology
  • Checkpoint blockade in the treatment of melanoma
  • Primary and secondary resistance to checkpoint blockade
  • Biomarkers of response
  • Discussion
 Katarina Mirjačić Martinović (SER)
14:30 – 15:10 Management of Advanced Melanoma – current, future with emerging data

  • Advanced melanoma – classification and mortality data
  • Registered treatments today, new treatments in development
  • Role of immunotherapy in advanced melanoma
  • What are the chances for long-term survival with immunotherapy and when to stop the treatment?
  • Evolving biomarker strategies
  • New data on checkpoint inhibitor therapy: sequential and combination treatment
  • Adjuvant treatment of melanoma in 2018
 Paul Lorigan (UK)
15:10 – 15:20 Break
15:20 – 16:10 Metastatic melanoma treatment in clinical practice: real world evidence

  • RWE from Slovenia
  • RWE from Croatia
  • RWE from Serbia
  • RWE from Bulgaria
  • RWE from Monenegro
 Janja Ocvirk (SLO)
Davorin Herceg (CRO)
Suzana Matković (SER)
Katerina Guenova  (BUL)
Nada Cicmil (MNE)
16:00 – 17:30 Immunooncology in clinical practice: case reports with panel discussion

Moderators: P. Lorigan, L. Kandolf Sekulovic, J. Ocvirk, D. Herceg, K. Kirov

8-10 case reports with panel discussion with the experts from the South-East European region

  • Identifying the most eligible patients
  • Immunotherapy in first or second-line
  • Assessment of tumor response
  • Treatment of brain metastases
  • Side-effects and how to recognise them
  • Cutaneous side-effects and role of dermatologist in oncology team
  • Treatment of mucosal melanoma
 Marija Ignjatović (SLO)
Luka Simetić  (CRO)
Željko Mijušković (SER)
Nina Dabelić (CRO)
Dobrica Nerić (SER)
Borislava Nikolin (SER)
Nada Cicmil (MNE)
Sanja Poduje (CRO)
Kristina Juškić (SER)
Tatjana Radević (SER)
17:30 – 17:45 Break
17:45 – 18:15 The Future of Immuno-Oncology in melanoma

  • The most promising candidates in phase I and II trials
  • Access to treatment in South-East Europe and worldwide
 Siniša Radulović
Lidija Kandolf Sekulović
18:15 – 18:30 Wrap up